331 related articles for article (PubMed ID: 11162404)
21. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.
Rao XC; Li S; Hu JC; Jin XL; Hu XM; Huang JJ; Chen ZJ; Zhu JM; Hu FQ
Protein Expr Purif; 2004 Jul; 36(1):11-8. PubMed ID: 15177279
[TBL] [Abstract][Full Text] [Related]
22. Purification of a recombinant membrane protein tagged with a calmodulin-binding domain: properties of chimeras of the Escherichia coli nicotinamide nucleotide transhydrogenase and the C-terminus of human plasma membrane Ca2+ -ATPase.
Egorov MV; Tigerström A; Pestov NB; Korneenko TV; Kostina MB; Shakhparonov MI; Rydström J
Protein Expr Purif; 2004 Jul; 36(1):31-9. PubMed ID: 15177281
[TBL] [Abstract][Full Text] [Related]
23. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
24. [Genetic engineering of human insulin. II. Exclusion HPLC of biotechnological precursors. Factors affecting resolution and selectivity].
Kliushnichenko VE; Vul'son AN
Bioorg Khim; 1993 Feb; 19(2):174-81. PubMed ID: 8498958
[TBL] [Abstract][Full Text] [Related]
25. Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5.
Luo X; Bathgate RA; Zhang WJ; Liu YL; Shao XX; Wade JD; Guo ZY
Amino Acids; 2010 Nov; 39(5):1343-52. PubMed ID: 20383778
[TBL] [Abstract][Full Text] [Related]
26. Integrated production of human insulin and its C-peptide.
Nilsson J; Jonasson P; Samuelsson E; Ståhl S; Uhlén M
J Biotechnol; 1996 Jul; 48(3):241-50. PubMed ID: 8862001
[TBL] [Abstract][Full Text] [Related]
27. Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B.
Son YJ; Kim CK; Kim YB; Kweon DH; Park YC; Seo JH
Biotechnol Prog; 2009; 25(4):1064-70. PubMed ID: 19572292
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two chemical cleavage methods for preparation of a truncated form of recombinant human insulin-like growth factor I from a secreted fusion protein.
Forsberg G; Baastrup B; Brobjer M; Lake M; Jörnvall H; Hartmanis M
Biofactors; 1989 Dec; 2(2):105-12. PubMed ID: 2696476
[TBL] [Abstract][Full Text] [Related]
29. [Biosynthesis of human calcitonin and mini-proinsulin in bacterial cells in the form of hybrid proteins with corresponding antisense peptides and a metal-binding peptide].
Efimov VA; Buriakova AA; Fradkov AF; Chakhmakhcheva OG
Bioorg Khim; 1996 Jul; 22(7):503-9. PubMed ID: 8992955
[TBL] [Abstract][Full Text] [Related]
30. Refolding and simultaneous purification of recombinant human proinsulin from inclusion bodies on protein-folding liquid-chromatography columns.
Yuan J; Zhou H; Yang Y; Li W; Wan Y; Wang L
Biomed Chromatogr; 2015 May; 29(5):777-82. PubMed ID: 25378200
[TBL] [Abstract][Full Text] [Related]
31. Use of the green fluorescent protein variant (YFP) to monitor MetArg human proinsulin production in Escherichia coli.
Daabrowski S; Brillowska A; Kur J
Protein Expr Purif; 1999 Jul; 16(2):315-23. PubMed ID: 10419827
[TBL] [Abstract][Full Text] [Related]
32. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
33. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli.
Xu X; Jin F; Yu X; Ji S; Wang J; Cheng H; Wang C; Zhang W
Protein Expr Purif; 2007 Jun; 53(2):293-301. PubMed ID: 17300953
[TBL] [Abstract][Full Text] [Related]
34. Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes.
Metlitskaia L; Cabralda JE; Suleman D; Kerry C; Brinkman J; Bartfeld D; Guarna MM
Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):339-45. PubMed ID: 15154847
[TBL] [Abstract][Full Text] [Related]
35. Expression, purification and characterization of recombinant human proinsulin.
Cowley DJ; Mackin RB
FEBS Lett; 1997 Feb; 402(2-3):124-30. PubMed ID: 9037180
[TBL] [Abstract][Full Text] [Related]
36. Double-C-peptide human proinsulin.
Wei G; Hu MH; Tang JG
Biochem Mol Biol Int; 1995 Jan; 35(1):37-46. PubMed ID: 7735138
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of bottlenecks in proinsulin secretion by Escherichia coli.
Mergulhão FJ; Taipa MA; Cabral JM; Monteiro GA
J Biotechnol; 2004 Apr; 109(1-2):31-43. PubMed ID: 15063612
[TBL] [Abstract][Full Text] [Related]
38. High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil.
Sun QM; Jiang HC; Xu WM; Liu X; Dai CB; Sun MS
Protein Expr Purif; 2005 Aug; 42(2):278-85. PubMed ID: 15935697
[TBL] [Abstract][Full Text] [Related]
39. High yield refolding and purification process for recombinant human interleukin-6 expressed in Escherichia coli.
Ejima D; Watanabe M; Sato Y; Date M; Yamada N; Takahara Y
Biotechnol Bioeng; 1999 Feb; 62(3):301-10. PubMed ID: 10099541
[TBL] [Abstract][Full Text] [Related]
40. Single-step trypsin cleavage of a fusion protein to obtain human insulin and its C peptide.
Jonasson P; Nilsson J; Samuelsson E; Moks T; Ståhl S; Uhlén M
Eur J Biochem; 1996 Mar; 236(2):656-61. PubMed ID: 8612642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
